Global Hepatitis C Drug Market to Hit $27.63 billion in 2020: Growth Analysis

Global Hepatitis C Drug Market to Hit $27.63 billion in 2020: Growth Analysis

News 0 Comment 12

Zion Market Research has published a new report titled “Hepatitis C Drug Market for (Hospitals, Private Labs, Physician Offices, Public Health Labs and Blood Banks) by Application – Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021” According to the report, global demand for hepatitis C drug market was valued at USD 11.81 billion in 2015, is expected to reach USD 27.63 billion in 2021 and is anticipated to grow at a CAGR of 17% between 2016 and 2021.

HCV is a major public health problem that attacks the liver and leads to inflammation. Certain drugs, toxins, heavy alcohol use, bacterial and viral infections can cause hepatitis infection. The most common types of hepatitis infections are Hepatitis A, Hepatitis B, and Hepatitis C and they are caused by three dissimilar viruses. Although each virus can cause similar symptoms, they have different modes of transmission and can affect the liver differently. Hepatitis C infection can bring both acute and chronic hepatitis disease. Approximately, 80% of patients get chronically infected with hepatitis C disease. Hepatitis C infection (HCV) spreads through the blood of an infected individual by the use of shared needles or supplies used to infuse drugs. Vaccines are available only for Hepatitis A and Hepatitis B viruses. Research into the development of a vaccine for hepatitis C is under way.

Request For Free Sample Report: http://www.marketresearchstore.com/report/hepatitis-c-drug-market-z62423#RequestSample

The prevalence of the infection, new productive treatments, relatively lesser time of treatment from before, and rising government subsidizing, can drive the hepatitis C drug market. Lack of awareness and information about HCV and treatment expense of disease can influence the hepatitis C market. In the last few years, a couple of new drugs have been launched in the market which has huge success and captured a maximum market share of the hepatitis C market. However, the cost of these drugs is too high. Hospitals, private labs, physician offices, public health labs, and blood banks are the key application of hepatitis C drug market.

Request For Free Price Quotation: http://www.marketresearchstore.com/requestquote?reportid=62423 

North America was one of the fastest growing hepatitis C drug markets across the world with more than 40% share of the total revenue generated in 2015. U. S. is the largest revenue contributor for worldwide Hepatitis C market. Government funding for drug development will continue to play an essential role in the growth of U.S. HCV treatment market. Europe was the second major market for Hepatitis C in 2015.

Browse the full report at: http://www.marketresearchstore.com/report/hepatitis-c-drug-market-z62423

Ongoing research and development in the pharmaceutical industry for hepatitis C drug development is expected to propel the market growth in the coming years. Moreover, interest for Hepatitis C medication is expanding in Asia-Pacific, Latin America and the Middle East and Africa due to the prevalence of the disease in the regions combined with expenditure on healthcare infrastructure.

Harvoni and Sovaldi are newly discovered drugs for Hepatitis C. Marketed by pharmaceutical giant Gilead Sciences and has more than 95% cure rate. The problem with this drug is its high cost, Harvoni drug is one of the expensive drug in the world. Some of the key player in the hepatitis C drugs market includes Merck & Co, Kenilworth, Roche, Basel GlaxoSmith, Gilead Sciences, AbbVie, Johnson & Johnson and Bristol-Myers Squibb.

The report segments the global hepatitis C drug market as

Application Segment Analysis: Hospitals, Private labs, Physician Offices, Public health labs, Blood banks

Regional Segment Analysis: North America (US), Europe(Germany, France, UK), Asia Pacific(China, Japan, India), Latin America(Brazil), Middle East and Africa

Visit Our Blog: https://marketresearchstore2017.wordpress.com

About Us: Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with Vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from Cardinal Industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Joel John
3422 SW 15 Street, Suit #8138
Deerfield Beach, Florida 33442
United States
Toll Free: +1-855-465-4651 (USA-CANADA)
Tel: +1-386-310-3803
Email: sales@marketresearchstore.com
Website: http://www.marketresearchstore.com

Author

shawn

Shawn Morgan is an accomplished digital marketing professional. He tracks the most recent patterns and happenings in the advanced showcasing scene, additionally offering his feeling on their effect on organizations. He has involvement in both B2C and B2B markets. His side interests incorporate perusing books and voyaging.

Leave a comment

Back to Top